A normal colposcopy examination fails to provide psychological reassurance for women who have had low-grade abnormal cervical cytology
S C Cotton,L Sharp,J Little,N M Gray,L G Walker,D K Whynes,M E Cruickshank,TOMBOLA Group,Maggie Cruickshank,Graeme Murray,David Parkin,Louise Smart,Eric Walker,Norman Waugh,Mark Avis,Claire Chilvers,Katherine Fielding,Rob Hammond,David Jenkins,Jane Johnson,Keith Neal,Rashmi Seth,Dave Whynes Ian Duncan,Alistair Robertson,Julian Little,Linda Sharp,Ian Russell,Leslie G Walker,Breda Anthony,Sarah Bell,Adrienne Bowie,Katrina Brown,Joe Brown,Kheng Chew,Claire Cochran,Seonaidh Cotton,Jeannie Dean,Kate Dunn,Jane Edwards,David Evans,Julie Fenty,Al Finlayson,Marie Gallagher,Nicola Gray,Maureen Heddle,Alison Innes,Debbie Jobson,Mandy Keillor,Jayne MacGregor,Sheona Mackenzie,Amanda Mackie,Gladys McPherson,Ike Okorocha,Morag Reilly,Joan Rodgers,Alison Thornton,Rachel Yeats,Tayside Lindyanne Alexander,Lindsey Bucha-nan,Susan Henderson,Tine Iterbeke,Susanneke Lucas,Gillian Manderson,Sheila Nicol,Gael Reid,Carol Robinson,Trish Sandilands,Nottingham Marg Adrian,Ahmed Al-Sahab,Elaine Bentley,Hazel Brook,Claire Bushby,Rita Cannon,Brenda Cooper,Ruth Dowell,Mark Dun-derdale,Dr Gabrawi,Li Guo,Lisa Heideman,Steve Jones,Salli Lawson,Zoe Philips,Christopher Platt,Shakuntala Prabhakaran,John Rippin,Rose Thompson,Elizabeth Williams,Claire Woolley,Massoud Boroujerdi,Kirsten Harrild,John Norrie,Nicholas Day,Theresa Marteau,Mahesh Parmar,Julietta Patnick,Ciaran Woodman,Doug Altman,Sue Moss,Michael Wells
DOI: https://doi.org/10.1111/cyt.12173
Cytopathology
Abstract:Objective: Worldwide, each year, large numbers of women are referred for colposcopy following low-grade abnormal cervical cytology. Many have no visible abnormality on examination. The risk of cervical intra-epithelial neoplasia grade 2/3 (CIN2/3) in these women is low. It is unknown whether, for women, a normal colposcopy resolves the anxiety which often follows the receipt of an abnormal cytology result. We investigated the prevalence of adverse psychological outcomes over 30 months following a normal colposcopy. Methods: This cohort study was nested within the UK TOMBOLA randomized controlled trial. Women aged 20-59 years, with recent low-grade cytology, who had a satisfactory colposcopy examination and normal transformation zone, completed the Hospital Anxiety and Depression Scale (HADS) and Process Outcome Specific Measure (POSM) at recruitment and during follow-up (12, 18, 24 and 30 months post-recruitment). Outcomes included percentages reporting significant anxiety (HADS anxiety subscale score ≥11), significant depression (HADS depression subscale score ≥8) or worries about the result of the next cytology test, cervical cancer, having sex, future fertility and general health at each time point (point prevalence) and during follow-up (cumulative prevalence). Results: The study included 727 women. All psychological measures (except depression) had high prevalence at recruitment, falling substantially by 12 months. During follow-up, the cumulative prevalence of significant anxiety was 27% and significant depression was 21%. The most frequently reported worry was that the next cytology test would be abnormal (cumulative prevalence of 71%; point prevalence of ≥50% at 12 and 18 months). The cumulative prevalence values of worries about cervical cancer, having sex and future fertility were 33%, 20% and 16%, respectively. Conclusions: For some women who have low-grade cytology, a normal colposcopy does not appear to provide psychological reassurance.